Publications by authors named "R Mina"

Claim this Profile
T
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.
Luciano J Costa, Nizar J Bahlis, Aurore Perrot, Ajay K Nooka, Jin Lu, Roberto Mina

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology.
Concetta Conticello, Vittorio Del Fabro, Alessandra Romano, Anna Mele, Roberto Mina

Ann Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network.
Niels W C J van de Donk, Philippe Moreau, Jesus F San-Miguel, Maria-Victoria Mateos, Meletios A Dimopoulos, Roberto Mina

Hemasphere· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy.
Concetta Conticello, Vittorio Del Fabro, Alessandra Romano, Anna Mele, Roberto Mina

Ann Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.
Haley D M Schuman, Sofia Barkova, Raèf Mina, Julie M Deleemans, Tina Nguyen

Integr Cancer Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis